MORISHITA JINTAN CO.,LTD.
| Market Cap | 9.4B |
| P/E Ratio | 16.18 |
| P/B Ratio | 0.74 |
| EPS | 133.78 |
| Dividend Yield | - |
| D/E Ratio | 0.47 |
| Current Ratio | 2.89 |
| Market Segment | Standard |
| Accounting | Japan GAAP |
| Currency | JPY |
Business Overview
Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In addition, the company offers OEM contract services. Further, it develops Jintan capsule technology that allows encapsulating various contents, such as powder, liquid, microbe or others. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Chuo, Japan.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | PHARMACEUTICAL |
| Market Segment | Standard |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2025 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | MORISHITA JINTAN CO.,LTD. |
| Ticker | 4524 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |
| Market Segment | Standard |
| Accounting | Japan GAAP |
| Fiscal Year | 2025 |
| Currency | JPY |
| Market Cap | 9.4B |
| Revenue | 12.8B |
| Net Income | 547.0M |
| P/E Ratio | 16.18 |
| EPS | 133.78 |
| Net Margin | 4.3% |
| ROE | 4.5% |
| Dividend Yield | - |
Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In addition, the company offers OEM contract services. Further, it develops Jintan capsule technology that allows encapsulating various contents, such as powder, liquid, microbe or others. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Chuo, Japan.